凱普生物(300639.SZ)及子公司擬繼續租賃關聯方潮州偉業房產 租金總額49萬元
格隆匯1月14日丨凱普生物(300639.SZ)公佈,鑑於公司正在擴建位於潮州市經濟開發試驗區北片高新區D5-3-3-4地塊的A幢廠房,為了不影響業務的正常開展,公司和全資子公司潮州凱普生物化學有限公司(“凱普化學”)擬繼續租賃關聯方偉業工藝(潮州)有限公司(“潮州偉業”)位於潮州市經濟開發試驗區高新區D5-5小區的B幢三層、四層以及C幢1層,總建築面積為2042㎡,續租期限為二年,續租價格按該地段同類型房屋的市場價格確定,與現執行的合同價格一致,續租期內租金總金額為49萬元。
公司董事長黃偉雄是潮州偉業的實際控制人,公司董事王建瑜擔任潮州偉業的副董事長,根據《深圳證券交易所股票上市規則》的有關規定,上述交易構成關聯交易。
公司及子公司向關聯方潮州偉業續租上述房屋分別作為辦公場所、倉庫和食堂,是公司經營發展需要,有合理的定價依據,關聯交易金額小,佔營業成本的比例小,不會對公司財務狀況和經營成果造成不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.